Read the March 2019 Digital Edition
The March 2019 digital edition includes the MM&M/Deloitte Healthcare Marketers Trend Report, the 2018 pro ad report, and more.
Print Issue: March 01, 2019
Wholesaler report: The opioid crisis, targeted medicines, and the state of partnerships
Executives from McKesson and Cardinal Health discuss the shift toward targeted medicines, wholesalers’ role in the opioid crisis, and current and future partnerships.
Immersive health technology has its coming-out party at CES 2019
The Consumer Electronics Show has become an early-year trend barometer for health tech, and this year was no different as immersive tech took center stage at the annual Las Vegas event.
Why health insurers want to cast pharma as a villain
Sander Flaum takes a look at why health insurers want to cast pharma as the villain.
Pro ad report 2018: Advertising remained flat year over year
While advertising in medical journals remained basically flat, the biggest players increased their volume of ad pages.
Let’s talk about co-pay card fraud
Tim Ogren, TrialCard’s SVP of product management, delves into co-pay card fraud.
Fingerpaint’s Ed Mitzen on predictions for 2019, his mentor, and watching Bravo
Ed Mitzen is the founder of Fingerpaint.
Deloitte Digital’s Larry Mickelberg on the Marketers Trend Report data: ‘We’re at the beginning of a pivot’
Deloitte Digital managing director Larry Mickelberg puts the survey results into context.
MM&M/Deloitte Healthcare Marketers Trend Report 2019: Budgets surged 26%, but good times could soon go up in smoke
Marketing budgets surged 26% this year, but with the industry in the government’s crosshairs, the good times aren’t likely to last.
Expect legislative baby steps, not big leaps on drug prices
Even though both parties agree on lowering drug prices, experts predict changes will be incremental.
